“…Diabetes status can be measured directly from biomarkers [68], such as fasting blood glucose (FBG), but also because insulin resistance (IR) and inflammation are important hallmarks of T2DM, biomarkers of inflammation, such as C-reactive protein (CRP), are also relevant. Most of the studies in this review used questionnaires and interviews, that collected information on treatment, blood glucose measurements, insulin, leptin, HbA1c, and CRP levels [69,70,71,72], but some studies carried out only blood tests of the above biomarkers [17,58,73], or used both methods [24,59,74]. …”